COAGULATION FACTOR VIIA RECOMBINANT HUMAN: Who Reports Side Effects? Age, Gender & Country Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Gender Distribution
30.4%
Female
69.6%
Male
Age Information
The average age of patients reporting adverse events with COAGULATION FACTOR VIIA RECOMBINANT HUMAN is 42.3 years.
Geographic Distribution
The majority of adverse event reports for COAGULATION FACTOR VIIA RECOMBINANT HUMAN originate from US.
Report Summary & Outcomes
952
Total Reports
952
As Primary/Secondary Suspect
382
Deaths Reported
328
Hospitalizations
59
Life-Threatening
11
Disabilities
Reporting Timeline
First adverse event report: 199101. Most recent report: 20250820. View full timeline →